Phathom Pharmaceuticals (PHAT)Simplify Asset Management Inc. reduced its stake -160K shares

522K

Shares reported · -160K vs prior quarter

0.25%

Disclosed portfolio weight

$5.01M

Reported value

Holdings as of

Jun 30, 2025

Filed

Aug 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 16, 2025InsiderOfficer sold ~$14K of PHAT shares in the open market

What came next

1. Sep 5, 2025InsiderOfficer sold ~$5.6K of PHAT shares in the open market
2. Oct 2, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective October 6, 2025, Sanjeev Narula was appointed as the Chief Financial and Business Officer of Phathom Pharmaceuticals, Inc. (the “Company”). Mr. Narula will also serve as principal financial officer of the Company, replacing Robert Breedlove, Vice President, Finance, who will continue to serve as principal accounting officer.”
3. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Phathom Pharmaceuticals

OQRO holds no insider, Congress, fund or contract record for Phathom Pharmaceuticals dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PHAT page.

How this filing works

• SEC Form 13F

Other disclosures at Phathom Pharmaceuticals

• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HROct 20, 2025
• SEC Form 4Sep 9, 2025
• SEC Form 13F-HRAug 14, 2025
• SEC Form 4Jul 18, 2025

Everything OQRO holds on this company is on its PHAT page.